Compounds > durapatite
Page last updated: 2024-08-21

durapatite and Cancer of Colon

durapatite has been researched along with Cancer of Colon in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Jia, J; Niu, X; Song, Q; Sun, L; Wang, L; Zhang, H; Zhang, Y; Zhang, Z; Zhao, H; Zheng, C1
Ansari, L; Bagheri, E; Derakhshi, M; Malaekeh-Nikouei, B; Shahtahmassebi, N1
Khoshtabiat, L; Matin, MM; Meshkini, A1
Azab, B; Dash, R; Fisher, PB; Kundu, SC; Mandal, M; Pathak, A; Prashanth Kumar, BN; Puvvada, N; Sarkar, D; Venkatesan, P1

Other Studies

4 other study(ies) available for durapatite and Cancer of Colon

ArticleYear
An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Nanoscale, 2019, Aug-29, Volume: 11, Issue:34

    Topics: Acrylic Resins; Administration, Oral; Animals; Chitosan; Colonic Neoplasms; Contrast Media; Delayed-Action Preparations; Durapatite; Fluorouracil; Gadolinium; Gefitinib; HT29 Cells; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles

2019
Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells.
    Pharmaceutical development and technology, 2020, Volume: 25, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Durapatite; Epirubicin; Female; Folic Acid; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyethylene Glycols; Porosity

2020
Fenton-magnetic based therapy by dual-chemodrug-loaded magnetic hydroxyapatite against colon cancer.
    Materials science & engineering. C, Materials for biological applications, 2021, Volume: 127

    Topics: Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Durapatite; Humans; Magnetic Fields; Magnetic Phenomena; Nanoparticles

2021
The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer.
    Biomaterials, 2011, Volume: 32, Issue:15

    Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Cycle; Cell Proliferation; Chitosan; Colonic Neoplasms; Cytoskeleton; Durapatite; HT29 Cells; Humans; Mice; Mice, Nude; Nanocomposites; Pyrazoles; Sulfonamides

2011